TNF-α and DNA Fragmentation in Muscle During Cancer Cachexia
Author Information
Author(s): Carbó N, Busquets S, van Royen M, Alvarez B, López-Soriano F J, Argilés J M
Primary Institution: Cancer Research Group, Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona
Hypothesis
Is TNF-α involved in the changes in skeletal muscle DNA content and integrity during cancer cachexia?
Conclusion
The study suggests that TNF-α partly mediates DNA fragmentation in skeletal muscle during cancer cachexia.
Supporting Evidence
- Chronic TNF treatment decreased skeletal muscle protein content by 21%.
- DNA fragmentation increased 4.6-fold in TNF-treated rats compared to controls.
- Tumor-bearing mice showed a 9.8-fold increase in muscle DNA fragmentation.
Takeaway
When cancer is present, a substance called TNF-α can cause muscle cells to break down their DNA, which is a sign of cell death.
Methodology
Rats were treated with TNF-α for 8 days, and DNA fragmentation was assessed in skeletal muscle.
Limitations
The study primarily used animal models, which may not fully replicate human conditions.
Participant Demographics
Male C57BL/6 mice and female Wistar rats were used in the experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website